Digital Health in Neurology Market
Digital Health in Neurology Market

Report ID: SQMIG35G2572

[email protected]
USA +1 351-333-4748

Digital Health in Neurology Market Size, Share, and Growth Analysis

Digital Health in Neurology Market

Digital Health in Neurology Market By Solution Type (Digital Therapeutics, Remote Patient Monitoring, Clinical Decision Support, Tele-neurology, Neurological Disease Management Platforms, Others), By Neurological Condition, By Technology, By Application, By End-Use Industry, By Region - Industry Forecast 2026-2033


Report ID: SQMIG35G2572 | Region: Global | Published Date: September, 2026
Pages: 157 |Tables: 159 |Figures: 78

Format - word format excel data power point presentation

Digital Health in Neurology Market Insights

Global Digital Health In Neurology Market size was valued at USD 0.16 Billion in 2024 and is poised to grow from USD 0.17 Billion in 2025 to USD 0.26 Billion by 2033, growing at a CAGR of 5.33% during the forecast period (2026-2033).

The primary driver of the global digital health in neurology market is the convergence of neuroimaging analytics and wearable sensor technology, which together enable continuous assessment of neurological function. This market comprises software platforms, tele‑medicine services, and AI‑powered diagnostic tools that target stroke, epilepsy, Parkinson’s disease, and multiple sclerosis. It matters because early detection and remote monitoring can reduce hospitalizations, lower costs, and improve quality of life. Historically, the sector moved from isolated prototypes in the 2000s to integrated ecosystems after the 2015 rollout of FDA‑approved mobile EEG devices, exemplified by adoption of the NeuroSky headband for home seizure tracking. Another pivotal factor driving market expansion is AI integration into therapeutic management, which converts sensor data into predictive risk scores that trigger timely actions. By turning monitoring into insights, health systems allocate resources more efficiently, decreasing acute admissions while earning revenue through reimbursable digital‑therapy codes. Real‑world deployments illustrate the effect: a partnership between the American Neurology Association and a cloud‑based AI platform cut seizure‑related ER visits by 27 % in a multicenter trial, and a European Parkinson’s tele‑rehab program doubled physiotherapy adherence, prompting drug‑development collaborations. These outcomes attract venture capital and backing, creating a loop that accelerates adoption and market growth.

How are AI and IoT reshaping digital health delivery in the neurology market?

AI and IoT are transforming digital health delivery in neurology by linking continuous data streams with intelligent analysis. AI algorithms interpret EEG, imaging and wearable sensor data to detect early signs of disease, while IoT devices transmit patient metrics to clinicians in real time. This integration enables remote monitoring of conditions such as epilepsy, Parkinson’s and multiple sclerosis, reducing the need for frequent clinic visits. Clinicians can personalize treatment plans based on dynamic insights, and patients gain greater autonomy over their health. The market is seeing rapid adoption as hospitals and startups collaborate to build interoperable platforms that improve outcomes and efficiency.NeuroPace announced an AI powered seizure forecasting system in October 2023, expanding the capability of its responsive neurostimulation platform to predict episodes before they occur. This advancement leverages continuous IoT sensor data and machine learning to enhance patient safety and streamline clinical decision making.

Market snapshot - (2026-2033)

Global Market Size

USD 0.16 Billion

Largest Segment

Neurological Disease Management Platforms

Fastest Growth

Digital Therapeutics

Growth Rate

5.33% CAGR

Digital Health in Neurology Market ($ Bn)
Country Share for North America Region (%)

To get more insights on this market click here to Request a Free Sample Report

Digital Health in Neurology Market Segments Analysis

Global digital health in neurology market is segmented by solution type, neurological condition, technology, application, end-use industry and region. Based on solution type, the market is segmented into Digital Therapeutics, Remote Patient Monitoring, Clinical Decision Support, Tele-neurology, Neurological Disease Management Platforms and Others. Based on neurological condition, the market is segmented into Epilepsy, Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Migraine and Others. Based on technology, the market is segmented into Artificial Intelligence, Wearable Devices, Mobile Applications, Cloud Computing and Others. Based on application, the market is segmented into Diagnosis, Treatment, Monitoring, Rehabilitation, Prevention and Others. Based on end-use industry, the market is segmented into Hospitals, Neurology Clinics, Rehabilitation Centers, Home Healthcare, Pharmaceutical and Biotechnology, Research Institutions and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

What role does monitoring play in enhancing epilepsy management within the digital health landscape?

Monitoring segment dominates because continuous observation of seizure frequency and intensity enables clinicians to fine‑tune medication regimens and intervene before crises amplify. Real time alerts delivered to caregivers and integrated analytics empower proactive care, reducing emergency visits and improving quality of life. The seamless integration of wearable EEG, mobile logging and cloud dashboards makes monitoring the indispensable backbone of digital epilepsy solutions for clinical decision support across care continuums.

Meanwhile, rehabilitation segment emerges as the key high growth area because novel neurofeedback platforms and virtual reality guided exercises are being adopted to restore motor and cognitive function after seizures. These tools extend care beyond acute management, attract reimbursement interest and stimulate collaborations with tech developers, thereby driving fresh revenue streams and expanding the overall market footprint.

how is artificial intelligence reshaping treatment personalization for Parkinson’s disease in digital neurology?

Artificial intelligence segment dominates because sophisticated machine learning models now analyze multimodal patient data to predict disease progression and suggest individualized therapy adjustments. This predictive capability shortens response cycles, improves symptom control, and supports clinicians in making evidence‑based decisions, fostering greater confidence in remote care pathways. The convergence of big data repositories, algorithmic transparency and clinician‑friendly interfaces consolidates AI as the core engine driving personalized Parkinson’s interventions.

However, wearable devices segment is witnessing the strongest growth momentum because continuous sensor streams provide the granular movement and physiological metrics required for AI algorithms to refine treatment loops. Advances in sensor accuracy, battery life and seamless connectivity boost patient adoption, while emerging partnerships between device makers and pharma accelerate integrated therapy solutions, propelling market expansion and opening new collaborative opportunities.

Digital Health in Neurology Market By Solution Type

To get detailed segments analysis, Request a Free Sample Report

Digital Health in Neurology Market Regional Insights

Why does North America Dominate the Global Digital Health in Neurology Market?

North America leads due to a mature ecosystem of research institutions, a robust network of technology innovators, and a regulatory environment that encourages rapid adoption of telemedicine and AI‑driven diagnostics. Strong reimbursement frameworks and high payer willingness to cover digital therapies further accelerate integration into standard neurological care. Collaboration between leading academic hospitals and venture‑backed startups creates a pipeline of evidence‑based solutions that quickly move from prototype to clinical practice. The market benefits from widespread broadband penetration, high consumer acceptance of remote health services, and a health‑system focus on improving outcomes for chronic neurological conditions while controlling costs. These converging factors reinforce a self‑sustaining cycle of investment, adoption, and refinement that sustains North America’s dominant position.

United States Digital Health in Neurology Market

Digital Health in Neurology Market in United States thrives on extensive federal research funding, a large network of specialized neurology centers, and a culture of early technology adoption. Integration of wearable sensing, cloud analytics, and virtual care platforms is supported by comprehensive insurer coverage and a competitive landscape of innovators. Collaborative initiatives between academic medical centers and technology firms accelerate validation of digital therapeutics, while patient demand for convenient, data‑driven care drives continuous expansion of service offerings.

Canada Digital Health in Neurology Market

Digital Health in Neurology Market in Canada benefits from a publicly funded health system that actively pilots digital solutions to improve access across vast geography. Provincial health authorities partner with technology providers to embed remote monitoring and AI‑assisted diagnostic tools within neurologic care pathways. Emphasis on evidence generation and cost‑effectiveness ensures that scalable solutions are adopted widely, while strong privacy regulations foster patient confidence in digital platforms. This collaborative, patient‑centered approach positions Canada as a key contributor to regional advancement.

What is Driving the Rapid Expansion of Digital Health in Neurology Market in Europe?

Europe’s expansion is propelled by coordinated policy initiatives that prioritize digital health integration across member states, combined with a highly skilled biomedical engineering workforce. Public‑private partnerships fund cross‑border research consortia focused on neuro‑degenerative disease monitoring and therapeutic adherence. Harmonized data standards facilitate interoperability, enabling seamless exchange of neurological data across hospitals and research labs. Reimbursement reforms in several countries encourage clinicians to adopt tele‑neurology and AI‑based decision support tools, while patient advocacy groups champion accessibility of remote care. Together these elements create a fertile environment for innovative digital neurology solutions to scale throughout the continent.

Germany Digital Health in Neurology Market

Digital Health in Neurology Market in Germany is anchored by a strong pharmaceutical and medical device industry that collaborates closely with leading university hospitals. National health insurance schemes increasingly reimburse digital monitoring platforms, fostering widespread clinician adoption. Robust data protection laws coexist with initiatives to create secure data exchange frameworks, enabling advanced analytics for disease progression. This combination of industrial capability, payer support, and regulatory clarity underpins Germany’s leading role in European digital neurology.

United Kingdom Digital Health in Neurology Market

Digital Health in Neurology Market in United Kingdom experiences accelerated growth thanks to government‑backed digital health strategies and a thriving startup ecosystem centered in major cities. National health service pilots integrate remote assessment tools and AI‑driven image analysis into routine neurology pathways, demonstrating clinical benefit and cost savings. Strong academic research centers contribute to evidence generation, while patient groups actively endorse virtual care options. These dynamics position United Kingdom as the fastest‑growing market in Europe for digital neurology solutions.

France Digital Health in Neurology Market

Digital Health in Neurology Market in France is emerging as innovators and health insurers collaborate on pilot projects for remote patient monitoring and cognitive rehabilitation apps. French health authorities promote reimbursement pathways for validated digital therapeutics, encouraging clinicians to incorporate them into practice. Academic research networks focus on validating biomarkers through wearable sensors, creating a pipeline of evidence‑based tools. This supportive policy environment combined with growing clinician interest fuels France’s emergence as a key European market.

How is Asia Pacific Strengthening its Position in Digital Health in Neurology Market?

Asia Pacific advances through strategic investments in digital infrastructure, a burgeoning pool of technology talent, and growing recognition of telehealth’s role in managing chronic neurological disorders. National health ministries in leading economies prioritize smart health initiatives, fostering partnerships between hospitals and tech firms to co‑develop AI‑enabled diagnostic platforms. Cultural acceptance of mobile health applications accelerates patient engagement, while regional collaborations promote standardization of data protocols. The focus on scalable, cost‑effective solutions tailored to diverse populations enables rapid diffusion of digital neurology services across the region, reinforcing its rising influence in the global market.

Japan Digital Health in Neurology Market

Digital Health in Neurology Market in Japan leverages a highly digitized healthcare system and strong government commitment to telemedicine expansion. Leading medical universities partner with technology companies to create wearable monitoring devices and AI‑driven assessment tools for conditions such as Parkinson’s disease. Reimbursement reforms support integration of remote care into routine practice, and a culturally ingrained respect for preventive health drives patient adoption. These factors collectively strengthen Japan’s position as a forefront innovator in digital neurology.

South Korea Digital Health in Neurology Market

Digital Health in Neurology Market in South Korea benefits from rapid broadband rollout and a tech‑savvy population eager to use mobile health solutions. Collaborative ecosystems between biotech firms, electronics manufacturers, and leading hospitals produce integrated platforms for real‑time symptom tracking and remote therapeutic guidance. Government incentives encourage clinical trials of digital therapeutics, while private insurers increasingly cover validated solutions. This convergence of technology, policy support, and consumer readiness propels South Korea’s growing influence in the Asia Pacific digital neurology landscape.

Digital Health in Neurology Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Digital Health in Neurology Market Dynamics

Drivers

Increasing Adoption of TeleNeurology

  • TeleNeurology platforms enable remote assessment, monitoring, and management of neurological disorders, thereby extending specialist reach to underserved regions and reducing patient travel burden. Clinicians can deliver timely interventions, adjust therapies, and engage patients through video consultations and digital biomarkers, fostering continuous care cycles. This connectivity enhances treatment adherence, accelerates clinical decision‑making, and supports collaborative research networks, collectively stimulating demand for integrated digital health solutions within neurology and driving market expansion across both public and private healthcare ecosystems, reinforcing investment and innovation pipelines.

Advancements in AI‑Driven Diagnostic Tools

  • AI‑driven diagnostic tools analyze neuroimaging, electrophysiological signals, and patient‑generated data to identify disease patterns with heightened accuracy and speed. These algorithms assist neurologists in differentiating among complex conditions, reducing misdiagnosis and enabling earlier therapeutic interventions. By integrating predictive analytics into clinical workflows, healthcare providers achieve personalized care pathways and optimize resource allocation. Such technological empowerment cultivates confidence among clinicians and patients, encouraging broader adoption of digital platforms and propelling growth of the neurology digital health market globally, fostering sustained sector momentum.

Restraints

Data Privacy and Security Concerns

  • Stringent data privacy regulations and heightened security concerns limit the collection, storage, and exchange of sensitive neurological information across digital platforms. Healthcare organizations must implement robust encryption, access controls, and compliance frameworks, which increase operational complexity and cost. Patient apprehension regarding unauthorized data use further discourages full engagement with remote monitoring tools. These barriers slow the deployment of scalable solutions, constrain cross‑institutional collaborations, and temper the overall pace of market adoption for digital health technologies in neurology globally, impacting long‑term growth.

Limited Reimbursement and Funding Models

  • Insufficient reimbursement frameworks and fragmented funding models impede the widespread integration of digital neurology solutions into routine clinical practice. Payers often lack clear criteria for covering teleconsultations, remote monitoring devices, and AI‑assisted diagnostics, leading to financial uncertainty for providers and patients alike. Without consistent reimbursement, healthcare institutions may hesitate to invest in necessary infrastructure or training, restricting scalability. This fiscal ambiguity curtails market momentum, deters innovative product development, and slows the overall diffusion of digital health technologies within the neurology sector.

Request Free Customization of this report to help us to meet your business objectives.

Digital Health in Neurology Market Competitive Landscape

The competitive landscape is shaped by aggressive M&A, strategic alliances and rapid tech innovation, with firms such as Google acquiring Fitbit to integrate wearable data into neurology monitoring, IBM Watson Health partnering with Mayo Clinic to develop AI‑driven diagnostic tools, and Philips launching an AI‑enhanced neuroimaging platform that leverages cloud analytics to accelerate clinical decision‑making. These moves intensify rivalry and drive adoption of interoperable digital health solutions across neurology providers.

  • Neuroverse: Established in 2021, their main objective is to accelerate early detection of neurodegenerative diseases through AI‑powered brain imaging analysis. Recent development: secured $45 million Series B funding to expand its cloud platform across Europe and launched a pilot program with three major academic hospitals for real‑time biomarker tracking.
  • CerebriAI: Established in 2020, their main objective is to deliver personalized digital therapeutics for epilepsy management using machine‑learning algorithms. Recent development: completed a successful FDA breakthrough device designation, raised $30 million in a Series A round, and began commercial rollout of its mobile app integrated with wearable seizure monitoring devices in North America.

Top Player’s Company Profile

  • Medtronic
  • Philips
  • GE HealthCare
  • Siemens Healthineers
  • Boston Scientific
  • Abbott
  • NeuroPace
  • Synchron
  • Ceribell
  • Rune Labs
  • Biofourmis
  • Koneksa Health
  • Click Therapeutics
  • Pear Therapeutics
  • Hinge Health
  • Teladoc Health
  • Doctor on Demand
  • Natus Medical
  • Compumedics
  • Neuroelectrics

Recent Developments

  • Siemens Healthineers launched a digital twin platform for acute stroke management in December 2025, integrating real‑time imaging, AI‑driven decision support, and remote monitoring to personalize treatment pathways. The solution enables clinicians to simulate therapeutic scenarios, improve workflow efficiency, and enhance patient outcomes across stroke centers worldwide and support collaborative research initiatives.
  • Philips introduced a cloud‑based neurology imaging analytics suite in January 2025, combining advanced MRI processing, machine‑learning algorithms, and secure data sharing to assist neurologists in diagnosing neurodegenerative disorders. The platform streamlines multi‑modal image interpretation, facilitates longitudinal patient monitoring, and integrates with existing hospital information systems for seamless clinical workflows across care.
  • NeuroPace received FDA clearance for its adaptive deep brain stimulation system targeting treatment‑resistant depression in March 2025, expanding beyond epilepsy indications. The device continuously monitors neural activity, automatically adjusts stimulation parameters, and provides clinicians with detailed analytics, aiming to improve therapeutic efficacy while reducing side‑effects for patients with severe mood disorders.

Digital Health in Neurology Key Market Trends

Digital Health in Neurology Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, the global digital health in neurology market is being propelled primarily by the surge in TeleNeurology adoption, which extends specialist care to remote patients and drives continuous engagement, while a second powerful catalyst is the integration of AI‑driven diagnostic tools that turn neuroimaging and sensor data into rapid, accurate insights. The monitoring segment, especially remote patient monitoring, leads the market by enabling real‑time seizure and movement tracking that refines treatment decisions. North America dominates the landscape thanks to mature research ecosystems, supportive reimbursement policies, and widespread broadband access. However, stringent data‑privacy and security regulations pose a significant restraint, slowing broader deployment of scalable solutions.

Report Metric Details
Market size value in 2024 USD 0.16 Billion
Market size value in 2033 USD 0.26 Billion
Growth Rate 5.33%
Base year 2024
Forecast period (2026-2033)
Forecast Unit (Value) USD Billion
Segments covered
  • Solution Type
    • Digital Therapeutics
    • Remote Patient Monitoring
    • Clinical Decision Support
    • Tele-neurology
    • Neurological Disease Management Platforms
    • Others
  • Neurological Condition
    • Epilepsy
    • Parkinson's Disease
    • Alzheimer's Disease
    • Multiple Sclerosis
    • Migraine
    • Others
  • Technology
    • Artificial Intelligence
    • Wearable Devices
    • Mobile Applications
    • Cloud Computing
    • Others
  • Application
    • Diagnosis
    • Treatment
    • Monitoring
    • Rehabilitation
    • Prevention
    • Others
  • End-Use Industry
    • Hospitals
    • Neurology Clinics
    • Rehabilitation Centers
    • Home Healthcare
    • Pharmaceutical and Biotechnology
    • Research Institutions
    • Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Medtronic
  • Philips
  • GE HealthCare
  • Siemens Healthineers
  • Boston Scientific
  • Abbott
  • NeuroPace
  • Synchron
  • Ceribell
  • Rune Labs
  • Biofourmis
  • Koneksa Health
  • Click Therapeutics
  • Pear Therapeutics
  • Hinge Health
  • Teladoc Health
  • Doctor on Demand
  • Natus Medical
  • Compumedics
  • Neuroelectrics
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Digital Health in Neurology Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Digital Health in Neurology Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Digital Health in Neurology Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Digital Health in Neurology Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Digital Health in Neurology Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Digital Health in Neurology Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300

REQUEST FOR SAMPLE

Please verify that you're not a robot to proceed!
Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Digital Health In Neurology Market size was valued at USD 0.16 Billion in 2024 and is poised to grow from USD 0.17 Billion in 2025 to USD 0.26 Billion by 2033, growing at a CAGR of 5.33% during the forecast period (2026-2033).

The competitive landscape is shaped by aggressive M&A, strategic alliances and rapid tech innovation, with firms such as Google acquiring Fitbit to integrate wearable data into neurology monitoring, IBM Watson Health partnering with Mayo Clinic to develop AI‑driven diagnostic tools, and Philips launching an AI‑enhanced neuroimaging platform that leverages cloud analytics to accelerate clinical decision‑making. These moves intensify rivalry and drive adoption of interoperable digital health solutions across neurology providers. 'Medtronic', 'Philips', 'GE HealthCare', 'Siemens Healthineers', 'Boston Scientific', 'Abbott', 'NeuroPace', 'Synchron', 'Ceribell', 'Rune Labs', 'Biofourmis', 'Koneksa Health', 'Click Therapeutics', 'Pear Therapeutics', 'Hinge Health', 'Teladoc Health', 'Doctor on Demand', 'Natus Medical', 'Compumedics', 'Neuroelectrics'

TeleNeurology platforms enable remote assessment, monitoring, and management of neurological disorders, thereby extending specialist reach to underserved regions and reducing patient travel burden. Clinicians can deliver timely interventions, adjust therapies, and engage patients through video consultations and digital biomarkers, fostering continuous care cycles. This connectivity enhances treatment adherence, accelerates clinical decision‑making, and supports collaborative research networks, collectively stimulating demand for integrated digital health solutions within neurology and driving market expansion across both public and private healthcare ecosystems, reinforcing investment and innovation pipelines.

Ai‑Driven Diagnostic Integration: The rapid adoption of artificial‑intelligence algorithms within neuroimaging platforms is reshaping clinical pathways. Machine‑learning models now assist neurologists in identifying early biomarkers of multiple sclerosis, epilepsy, and stroke with unprecedented speed. Integrated AI tools streamline data aggregation from wearables, electronic health records, and imaging, creating unified patient profiles that support proactive intervention. This convergence accelerates diagnostic confidence, reduces referral cycles, and positions digital health firms as essential partners in neuroscience care delivery, driving continuous learning loops across global healthcare ecosystems.

Why does North America Dominate the Global Digital Health in Neurology Market? |@12
AGC3x.webp
Aisin3x.webp
ASKA P Co. LTD3x.webp
BD3x.webp
BILL & MELIDA3x.webp
BOSCH3x.webp
CHUNGHWA TELECOM3x.webp
DAIKIN3x.webp
DEPARTMENT OF SCIENCE & TECHNOLOGY3x.webp
ETRI3x.webp
Fiti Testing3x.webp
GERRESHEIMER3x.webp
HENKEL3x.webp
HITACHI3x.webp
HOLISTIC MEDICAL CENTRE3x.webp
Institute for information industry3x.webp
JAXA3x.webp
JTI3x.webp
Khidi3x.webp
METHOD.3x.webp
Missul E&S3x.webp
MITSUBISHI3x.webp
MIZUHO3x.webp
NEC3x.webp
Nippon steel3x.webp
NOVARTIS3x.webp
Nttdata3x.webp
OSSTEM3x.webp
PALL3x.webp
Panasonic3x.webp
RECKITT3x.webp
Rohm3x.webp
RR KABEL3x.webp
SAMSUNG ELECTRONICS3x.webp
SEKISUI3x.webp
Sensata3x.webp
SENSEAIR3x.webp
Soft Bank Group3x.webp
SYSMEX3x.webp
TERUMO3x.webp
TOYOTA3x.webp
UNDP3x.webp
Unilever3x.webp
YAMAHA3x.webp
Yokogawa3x.webp

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Feedback From Our Clients